Comparison Between Egyptian MTA, Biodentine Versus Calcium Hydroxide as Indirect Pulp Capping Materials In Permanent Teeth
Recruiting
Phase 4
Interventional Study
Deep Caries
Indirect Pulp Capping
Mineral Trioxide Aggregate (MTA)
Calcium Hydroxide
Biodentine
Patient Reported Outcome Measures
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 22 – 45
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 35 (estimated)
- Sponsor
- Cairo University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Compare the clinical performance and patient satisfaction of Egyptian MTA, Biodentine versus Calcium Hydroxide as indirect pulp capping materials in permanent teeth
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patients aged 22: 45 years old.
* Males or females.
* Patients with vital teeth with deep carious lesions.
* Patients in good general health.
* Good oral hygiene.
* Co-operative patients who show interest to participate in the study.
Exclusion Criteria:
* Patients with…
Contacts